SMAD1 antibody (AA 20-330)
Quick Overview for SMAD1 antibody (AA 20-330) (ABIN6242630)
Target
See all SMAD1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 20-330
-
Purification
- This antibody is purified through a protein G column, followed by dialysis against PBS.
-
Immunogen
- This SMAD1 antibody is generated from a mouse immunized with a recombinant protein between 20-330 amino acids from human SMAD1.
-
Isotype
- IgG1 kappa
-
-
-
-
Application Notes
- IF: 1:25. WB: 1:2000. IHC-P: 1:25. IHC-P: 1:25
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified monoclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Expiry Date
- 6 months
-
-
- SMAD1 (SMAD, Mothers Against DPP Homolog 1 (SMAD1))
-
Alternative Name
- SMAD1
-
Background
- Transcriptional modulator activated by BMP (bone morphogenetic proteins) type 1 receptor kinase. SMAD1 is a receptor-regulated SMAD (R-SMAD). SMAD1/OAZ1/PSMB4 complex mediates the degradation of the CREBBP/EP300 repressor SNIP1. May act synergistically with SMAD4 and YY1 in bone morphogenetic protein (BMP)-mediated cardiac-specific gene expression.
-
Molecular Weight
- 52260
-
UniProt
- Q15797
-
Pathways
- Stem Cell Maintenance, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
Target
-